A clinical-neuropathological study shows that the lateral sclerosis of ALS reflects a length-dependent dying-back ...
Safety standards, luxury features, and advanced tech are making modern performance cars faster and safer, but heavier than ...
When Daniel Park, MD, began learning endoscopic spine surgery nearly a decade ago, the surgeons coming up behind him barely knew what to make of it. Fellowship applicants would hear “endoscopic” and ...
ASX healthcare is continuing its recovery after defying a historically softer September to be the top performing sector for ...
Introduction“Tighten your stomach and brace your core.” If you teach deadlifts or squats, you have likely used this cue at ...
Spread the love“`html It’s a statistic that should send shivers down your spine: nearly 60% of critical infrastructure ...
NTAP effective October 1, 2026, expanding access to icotec's radiolucent spinal stabilization technology for eligible ...
A five-day Alpine expedition study found that climbers who developed moderate-to-severe high-altitude headache showed significant rises in tear fluid CGRP, the neuropeptide central to migraine, ...
The Transmitter asked 17 neuroscientists what questions might remain unanswered if support for nonhuman primate research ...
A Stanford study suggests the human brain developed from two ancient nervous systems, offering new insights into evolution and potential research on ALS and SMA.
Every spinal cord stimulator case now has a threshold preemption fight, and as of October 2 the answer to that fight depends on which company made ...
PathMaker Neurosystems Inc. (“PathMaker”), a clinical-stage neurotechnology company developing a breakthrough non-invasive treatment for Amyotrophic Lateral Sclerosis (ALS, Lou Gehrig’s disease), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results